Compendia

Jefferies raised the price target of Medivation Inc (NASDAQ: MDVN) shares to $52 from $39 after its survey showed "meaningful improvement" in the market for Xtandi on almost all fronts. The Physician Survey Jefferies conducted a physician survey "to gauge the outlook for Medivation's Xtandi given...